share_log

JMP Securities Maintains Market Outperform on HOOKIPA Pharma, Raises Price Target to $24

Benzinga ·  Aug 10, 2024 02:36  · Ratings

JMP Securities analyst Roy Buchanan maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Market Outperform and raises the price target from $23 to $24.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment